Primary end point was met, with overall response for 74, 67, and 50 percent receiving axatilimab 0.3 mg, 1 mg, and 3 mg per kilogram of body weight ...

Refractory alloys like Niobium C103 are increasingly being used in conjunction with 3D printing for hypersonic applications.

For patients with recurrent or refractory graft-versus-host disease (GVHD), the colony-stimulating factor 1 receptor ...

The primary goals of the study are to evaluate the safety and overall response rate in patients who are given RLS-0071.

CERATIZIT and PLANSEE to showcase refractory metal AM at Formnext presenting parts made of molybdenum, tungsten and cemented ...

The refractory cement market is essential for industries requiring materials that can withstand high temperatures, such as steel production, cement manufacturing, and petrochemicals. Driven by the ...

Three different doses of Niktimvo all had high rates of response among patients with recurrent or refractory ...

From solutions for the regenerator and the melting end to the new, advanced FouRrath4 feeder expendables series, newly developed channel blocks and innovative ceramic hot gas filter elements, Rath ...

Findings from the phase 3 SIERRA study showed that Iomab-B was associated with a higher durable complete response rate vs ...

A retrospective study of treatment-refractory chronic neck pain secondary to cervical facet arthropathy showed long-lasting pain relief with c-RFA.

Agenus Inc. ("Agenus") (Nasdaq: AGEN), a leader in developing novel immunological agents to treat various cancers, today announced that updated data from the clinical trial of botensilimab and ...

(“Agenus”) (Nasdaq: AGEN), a leader in developing novel immunological agents to treat various cancers, presented data today at the European Society for Medical Oncology (ESMO) Congress held in ...